[#item_full_content] The U.S. Drug Enforcement Administration and a pair of hemp product companies are butting heads in the Fourth and Ninth Circuits over a newly enacted DEA rule expressly listing hexahydrocannabinol, or HHC, as a Schedule I substance under the Controlled Substances Act. 
Read More
